Clinical Characteristics, Outcomes, and Risk Factors for Mortality in Patients with Stenotrophomonas maltophilia Bacteremia

Synergistic antibacterial effects of colistin in combination with aminoglycoside, carbapenems, cephalosporins, fluoroquinolones, tetracyclines, fosfomycin, and piperacillin on multidrug resistant Klebsiella pneumoniae isolates

(2021) Julalak C. Ontong et al.   PLoS One

Stenotrophomonas maltophilia Infections: Clinical Characteristics and Factors Associated with Mortality of Hospitalized Patients

(2020) Worachart Insuwanno et al.   Infection and Drug Resistance

Clinical Features, Outcomes, and Risk Factors of Bloodstream Infections due to Stenotrophomonas maltophilia in a Tertiary-Care Hospital of China: A Retrospective Analysis

(2019) Yibing Chen et al.   Biomed Research International

Antimicrobial susceptibility testing of colistin – evaluation of seven commercial MIC products against standard broth microdilution for Escherichia coli , Klebsiella pneumoniae , Pseudomonas aeruginosa , and Acinetobacter spp.

(2018) E. Matuschek et al.   CLINICAL MICROBIOLOGY AND INFECTION

Risk factors for mortality in patients with Stenotrophomonas maltophilia bacteremia

(2016) Yong Duk Jeon et al.   MEDICINE

Clinical characteristics and risk factors of infections caused by Stenotrophomonas maltophilia in a hospital in northwest China

(2014) Meng Xun et al.   Journal of Infection in Developing Countries

Monotherapy with Fluoroquinolone or Trimethoprim-Sulfamethoxazole for Treatment of Stenotrophomonas maltophilia Infections

(2013) Yu Lin Wang et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Can Levofloxacin Be a Useful Alternative to Trimethoprim-Sulfamethoxazole for Treating Stenotrophomonas maltophilia Bacteremia?

(2013) Sun Young Cho et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Risk factors influencing mortality related to Stenotrophomonas maltophilia infection in hematology–oncology patients

(2013) Hayati Demiraslan et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Antimicrobial Susceptibility of Stenotrophomonas maltophilia Isolates from Korea, and the Activity of Antimicrobial Combinations against the Isolates

(2013) Hae-Sun Chung et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Stenotrophomonas maltophilia bloodstream infection: Comparison between community-onset and hospital-acquired infections

(2012) Ya-Ting Chang et al.   JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION

Stenotrophomonas maltophilia Infections in a General Hospital: Patient Characteristics, Antimicrobial Susceptibility, and Treatment Outcome

(2012) George Samonis et al.   PLoS One

Attributable mortality ofStenotrophomonas maltophiliainfections: a systematic review of the literature

(2009) Matthew E Falagas et al.   Future Microbiology

Stenotrophomonas maltophilia: an emerging opportunist human pathogen

(2009) W John Looney et al.   LANCET INFECTIOUS DISEASES

Factors associated with mortality in patients with bloodstream infection and pneumonia due to Stenotrophomonas maltophilia

(2008) J. I. Garcia Paez et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Risk factors associated with mortality of infections caused by Stenotrophomonas maltophilia: a systematic review

(2008) J.I. Garcia Paez et al.   JOURNAL OF HOSPITAL INFECTION